Basilea Pharmaceutica AG
Nam.-Aktien SF 1
ISIN: CH0011432447WKN: A0B9GAWährung: EUR
40,10 EUR
-1,60 %
-0,65
Börse:
Stand:
30.04.
{"main_chart_height":320,"indicator_chart_height":60,"zoom":false,"show_dash":["inline-timespan"],"hover_tooltip":true,"i18n":{"de":{"Intraday":"1T","7d":"1W","1m":"1M","3m":"3M","6m":"6M","1Y":"1J","3Y":"3J","5Y":"5J","10Y":"10J"}},"hover_labels":["close","perf"],"watermark":{"imgSrc":"https:\/\/www.goyax.de\/wp-content\/themes\/goyax\/assets\/images\/goyax-logo.svg","x":0.98,"y":0.98,"opacity":0.5,"height":31,"width":150},"xAxis":{"fontFamily":"Roboto","fontSize":14},"yAxis":{"fontFamily":"Roboto","fontSize":14,"showGrid":true},"view_span":"6m","enable_intraday":true,"locked_features":{"features":["downloads-csv","timespan-10Y"],"redirect":"https:\/\/www.goyax.de\/anmelden\/?redirect=%2Faktien%2FCH0011432447%2Fbasilea-pharmaceutica-ag%2F"},"main_instrument":{"label":"Basilea Pharmaceutica AG","params":{"isin":"CH0011432447","boerse":"ls","span":"5y"},"intraday_endpoint_url":"?mode=intraday"}}| Börse / Markt | Letzter | Kurszeit | Gehand. Stk. | Umsatz EUR |
|---|---|---|---|---|
| Lang & Schwarz | 40,10EUR | 30.04. | 70 | 2.807,00 |
Statistiken
| 7 Tage | 1 Monat | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | |
|---|---|---|---|---|---|---|
| Performance [%] | -3,02 | +4,56 | +9,12 | -8,34 | -2,05 | +2,90 |
| Volatilität [%] | 9,274 | 42,75 | 34,29 | 30,77 | 33,20 | 36,67 |
| Sharpe-Ratio | -21,08 | 1,375 | 0,6214 | -0,1849 | 0,0861 | 0,1448 |
| Hoch | 42,25 | 45,00 | 45,00 | 51,30 | 56,00 | 56,95 |
| Tief | 39,75 | 37,55 | 33,90 | 33,90 | 28,15 | 27,62 |
| Hist. Kurs | 41,35 | 38,35 | 36,75 | 43,75 | 40,94 | 38,97 |
| Gehand. Stk. | 2,80 Tsd. | 85,00 Tsd. | 384,40 Tsd. | 662,10 Tsd. | 1,59 Mio. | 2,88 Mio. |
| Max. Verlust | -3,023 | -7,922 | -13,58 | -32,84 | -38,98 | -49,46 |
Portrait
Basilea Pharmaceutica AG is an independent biopharmaceutical company actively engaged in the discovery and development of innovative drugs for the treatment of bacterial infections, fungal infections and skin diseases associated with high unmet medical needs. Basilea focuses its resources and capabilities on the discovery, development and eventual marketing of innovative medicines. The company is headquartered in Basel, Switzerland.
Webseite http://www.basilea.com
Quotes
- Geld (30.04.)40,10
- Brief (30.04.)40,70
- Spread (in %)0,6000 (1,50 %)
- Geld Stk.119
- Brief Stk.119
Kursdaten
- Eröffnungskurs40,75
- Tageshoch41,10
- Tagestief39,75
- Kurs (30.04.2024)40,10
- Umsatz EUR2.807,00
- Gehand. Stk.70
Kursdaten Vortag
- Vortag-Eröffnung41,10
- Vortag-Hoch41,30
- Vortag-Tief40,35
- Vortag-Schlusskurs40,75
Stammdaten
- WertpapiertypAktie
- ISINCH0011432447
- WKNA0B9GA
- BranchenPharma-Hersteller
{"main_chart_height":350,"indicator_chart_height":80,"zoom":true,"show_dash":["chart-types","timespan","quicksearch","indicators","downloads"],"hover_tooltip":true,"i18n":{"de":{"Intraday":"1T","7d":"1W","1m":"1 Monat","3m":"3 Monate","6m":"6 Monate","1Y":"1 Jahr","3Y":"3 Jahre","5Y":"5 Jahre","10Y":"10 Jahre"}},"hover_labels":["open","high","low","close"],"watermark":{"imgSrc":"https:\/\/www.goyax.de\/wp-content\/themes\/goyax\/assets\/images\/goyax-logo.svg","x":0.98,"y":0.98,"opacity":0.5,"height":31,"width":150},"xAxis":{"fontFamily":"Roboto","fontSize":14},"yAxis":{"fontFamily":"Roboto","fontSize":14,"showGrid":true},"locked_features":{"features":["downloads-csv","timespan-10Y"],"redirect":"https:\/\/www.goyax.de\/anmelden\/?redirect=%2Faktien%2FCH0011432447%2Fbasilea-pharmaceutica-ag%2F"},"show_volume":true,"indicators":[],"view_span":"5y","chart_type":"line","main_instrument":{"label":"Basilea Pharmaceutica AG","params":{"isin":"CH0011432447","boerse":"ls","span":"5y"}},"chart_labels":["main",["d","o","h","l","c"],"performance"],"preset_indicators":[{"key":"ema","option":{"days":50,"color":"#1f77b4"}},{"key":"ema","option":{"days":200,"color":"#ff7f0e"}},{"key":"rsi"}],"quicksearch":{"url":"https:\/\/www.goyax.de\/wp-json\/goyax\/v1\/search","search_field":"s","params":{"charting":1}}}